Microbix Biosystems Inc.

(MBX:CA)

By |

Profile

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen and QAPs and Other. It generates maximum revenue from the Antigen and QAPs segment. Geographically, it derives a majority of revenue from North America.

Contact Information

Website: www.microbix.com
Email: investor.relations@microbix.com
Main Phone: +1 905 361-8910
Address: 265 Watline Avenue
State: ON
City / Town: Mississauga
Country: CA
Postal Code: L4Z 1P3

Issuer Information

Exchange: TSX
CEO: Cameron Groome
Employees: 70
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

Profile

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen and QAPs and Other. It generates maximum revenue from the Antigen and QAPs segment. Geographically, it derives a majority of revenue from North America.

Contact Information

Website: www.microbix.com
Email: investor.relations@microbix.com
Main Phone: +1 905 361-8910
Address: 265 Watline Avenue
State: ON
City / Town: Mississauga
Country: CA
Postal Code: L4Z 1P3

Issuer Information

Exchange: TSX
CEO: Cameron Groome
Employees: 70
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

$ 0.59 $ -0.01 (-1.67%)
Last Price 0.59 Change $ -0.01 Change % -1.67 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.62 High 0.62 Low 0.53 Prev Close 0.60
Last Trade Volume 184,221 52 Wk Hi 0.67 52 Wk Low 0.18
Market Cap 64.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 110,136,580.00 EPS (TTM) -0.05 PE Ratio -11.30 Exchange TSX